1245794-53-9Relevant articles and documents
HETEROCYCLIC COMPOUNDS AS INHIBITORS OF HPK1
-
Page/Page column 180-181, (2021/01/29)
This disclosure relates to heterocyclics as inhibitors of HPK1, in particular relates to a compound of Formula I or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising said compound that useful for treatment of HPK1 mediated diseases and conditions such as cancer. (I)
TBK/IKK INHIBITOR COMPOUNDS AND USES THEREOF
-
Paragraph 1138; 1140, (2017/01/23)
The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as TBK/IKKε inhibitors.